{
    "2019-06-26": [
        [
            {
                "time": "",
                "original_text": "恒瑞医药董监高减持股份进展公告 减持股份",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "董监高",
                        "减持",
                        "股份"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "恒瑞医药(600276.SH)11名高管累计减持合计181.65万股",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "高管",
                        "减持",
                        "181.65万股"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "医疗保健：安徽省率先开始省级高值耗材带量谈判 荐6股",
                "features": {
                    "keywords": [
                        "医疗保健",
                        "安徽省",
                        "高值耗材",
                        "带量谈判"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗保健"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药板块表现强势，机构：不惧政策扰动，把握高确定性投资主线",
                "features": {
                    "keywords": [
                        "医药板块",
                        "表现强势",
                        "政策扰动",
                        "高确定性",
                        "投资主线"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "【医药】安徽省率先开始省级高值耗材带量谈判――医药行业周报――中性（联系人：甘英健，陈晨）",
                "features": {
                    "keywords": [
                        "医药",
                        "安徽省",
                        "高值耗材",
                        "带量谈判",
                        "医药行业周报"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "市场潜力大 PD-1或成创新药“黄金赛道”",
                "features": {
                    "keywords": [
                        "市场潜力",
                        "PD-1",
                        "创新药",
                        "黄金赛道"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}